Afelimomab | definition of Afelimomab by Medical dictionary
Also found in: Wikipedia
Afelimomab An anti-TNF-alpha monoconal antibody which advanced to phase 3 trials for managing sepsis and septic shock, but only offered a marginal improvement over the control arm, and has been abandoned.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive
within 24 hours of controls meeting enrollment criteria Sepsis or septic 16 Post-ICU admission shock days 1, 2, or 3 Phase II/III therapeutic trials Severe sepsis 1342 Placebo 12 hours before patients with or controlled receiving drug to without septic day 28 shock (Lenercept trial) Sepsis 48 Placebo 0-168 hours after (Afelimomab
trial) controlled drug infusion Sepsis 944 Placebo Baseline to ?